SEC Form D · Amendment · filed July 27, 2023
Kriya Therapeutics, Inc
Rule 506(b): private placement to accredited investors, no public advertising.
People & firms on this filing (28)
Roger Jeffs · Palo Alto, CADirectorIlan Oren · Palo Alto, CADirectorKeith Manchester · Palo Alto, CADirectorShankar Ramaswamy · Palo Alto, CAExec · DirectorJames Momtazee · Louisville, KYDirectorNeelaksh Varshney · Redwood City, CADirectorDana Johnson · San Mateo, CAExecBritt Petty · Palo Alto, CAExecMichele Stone · Palo Alto, CAExecCurt Herberts · Palo Alto, CAExecSaira Ramasastry · Raleigh, NCDirectorAmber Ramsey · George Town, Cayman IslandsDirectorH. L. Remmel · New York, NYDirectorJohn T. Pena · New York, NYExec · DirectorChetan R. Mukundan, M.D · Nashville, TNDirectorTrit Garg · Palo Alto, CADirectorMatthew Kinley · Los Angeles, CADirectorMichael V. Banks · AUSTIN, TXDirectorEric D. Andersen · Los Angeles, CAExec · DirectorEd Murray · Davie, FLDirectorJames Momtazee · Louisville, KYDirectorNeelaksh Varshney · Redwood City, CADirectorDana Johnson · Fargo, NDExecBritt Petty · Palo Alto, CAExecTrit Garg · Palo Alto, CADirectorMichele Stone · Palo Alto, CAExecCurt Herberts · Palo Alto, CAExecSaira Ramasastry · Austin, TXDirector Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗